跳转至内容
Merck
CN

V900932

Sigma-Aldrich

D -(+)-海藻糖 二水合物

Vetec, reagent grade, ≥99%

别名:

D-(+)-海藻糖 二水合物, α,α-海藻糖, α-D-吡喃葡萄糖基-α-D-吡喃葡萄糖苷

登录查看公司和协议定价

关于此项目

经验公式(希尔记法):
C12H22O11 · 2H2O
CAS Number:
分子量:
378.33
Beilstein:
5322018
EC 号:
MDL编号:
UNSPSC代码:
12352201
PubChem化学物质编号:
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助
技术服务
需要帮助?我们经验丰富的科学家团队随时乐意为您服务。
让我们为您提供帮助

等级

reagent grade

产品线

Vetec

方案

≥99%

表单

powder

储存温度

room temp

SMILES字符串

[H]O[H].[H]O[H].OC[C@H]1O[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)[C@H](O)[C@@H](O)[C@@H]1O

InChI

1S/C12H22O11.2H2O/c13-1-3-5(15)7(17)9(19)11(21-3)23-12-10(20)8(18)6(16)4(2-14)22-12;;/h3-20H,1-2H2;2*1H2/t3-,4-,5-,6-,7+,8+,9-,10-,11-,12-;;/m1../s1

InChI key

DPVHGFAJLZWDOC-PVXXTIHASA-N

正在寻找类似产品? 访问 产品对比指南

应用


  • 用于局部缓释治疗牙周病的喷雾干燥封装吉非替尼微颗粒。:该研究探讨了如何利用D-(+)-海藻糖二水合物开发喷雾干燥包封吉非替尼微粒,用于牙周病的缓释治疗。该研究强调了这种方法在局部持续给药方面的潜力,可提高疗效并减少全身副作用(Baldelli et al., 2023)。

  • 关于可吸入微粒喷雾干燥过程中亮氨酸的颗粒形成。:该研究探讨了在喷雾干燥亮氨酸以制造可吸入微颗粒的过程中颗粒形成的机理。该研究深入探讨了D-(+)-海藻糖二水合物在稳定微粒和改善其气溶胶特性方面的作用,这对开发高效的可吸入微粒至关重要(Ordoubadi et al., 2021)。

其他说明

为了全面了解我们针对客户研究提供的各种二糖产品,建议您访问我们的碳水化合物分类页面。

法律信息

Vetec is a trademark of Merck KGaA, Darmstadt, Germany

储存分类代码

11 - Combustible Solids

WGK

WGK 1

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

涉药品监管产品

历史批次信息供参考:

分析证书(COA)

Lot/Batch Number

没有发现合适的版本?

如果您需要特殊版本,可通过批号或批次号查找具体证书。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Sabine Ullrich et al.
Journal of pharmaceutical sciences, 104(6), 2040-2046 (2015-04-03)
The importance of cake adhesion to the inside vial wall during lyophilization of amorphous trehalose cakes was determined by using hydrophobized vials. The degrees of cake shrinkage and cracking were determined independently by photographic imaging of the cake top surface
Alan Twomey et al.
International journal of pharmaceutics, 487(1-2), 91-100 (2015-04-19)
In frozen and lyophilized systems, the biological to be stabilized (e.g. therapeutic protein, biomarker, drug-delivery vesicle) and the cryo-/lyo-protectant should be co-localized for successful stabilization. During freezing and drying, many factors cause physical separation of the biological from the cryo-/lyo-protectant
Sabine Ullrich et al.
Pharmaceutical research, 32(8), 2503-2515 (2015-02-06)
Measurement of the kinetic development of shrinkage and cracking of an amorphous trehalose cake as they take place during lyophilization. A novel technique has been developed which monitors a vial in situ during the freeze-drying cycle. The 2-dimensional degrees of
Anke Sass et al.
Drug development and industrial pharmacy, 40(6), 749-757 (2013-04-20)
The spray-drying behaviour of 16 water-miscible organic solvents on a bench-scale machine (Büchi B290 with inert loop) was determined under mild-to-moderate process conditions, namely inlet gas temperature of 130 °C and liquid feed flow rate of ≤3 mL/min. The solvents with boiling
Matthias Erber et al.
International journal of pharmaceutics, 495(2), 692-700 (2015-09-24)
A cryopellet formulation of the diagnostic protein ecarin has been developed that is suitable for use to monitor blood coagulation via in vitro thromboelastometry. The coagulation activity of the ecarin was measured by thromelastometry using whole blood. In aqueous solution

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系客户支持